Eargo Rises on FDA Hearing Aid Announcement

By Josh Beckerman

Eargo Inc. shares rose 27% to $1.45 after the U.S. Food and Drug Administration said it would allow some hearing aids to be sold over-the-counter.

The FDA said the move will "improve access to hearing aids which may in turn lower costs for millions of Americans." It enables customers "with perceived mild to moderate hearing impairment to purchase hearing aids directly from stores or online retailers without the need for a medical exam, prescription or a fitting adjustment by an audiologist."

Write to Josh Beckerman at [e-mail]

(END) Dow Jones Newswires

08-16-22 1458ET